Serina Therapeutics
SER
35 hedge funds and large institutions have $5.28M invested in Serina Therapeutics in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
18% more capital invested
Capital invested by funds: $4.46M → $5.28M (+$823K)
13% more funds holding
Funds holding: 31 → 35 (+4)
0.01% more ownership
Funds ownership: 0.36% → 0.36% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$25.6K |
| 2 |
Jane Street
New York
|
+$21.6K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$20.4K |
| 4 |
SWIG
Strategic Wealth Investment Group
Louisville,
Kentucky
|
+$14.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$38K |
| 2 |
Morgan Stanley
New York
|
-$108 |
| 3 |
DC
Defender Capital
Charlotte,
North Carolina
|
-$81 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RAM
26
Riggs Asset Management
Dallas,
Pennsylvania
| $1K | – | – | – |
|
27
Bank of America
Charlotte,
North Carolina
| $1K | +$27 | +1 | +3% |
|
28
BNP Paribas Financial Markets
Paris,
France
| $691 | – | – | – |
|
|
29
Citadel Advisors
Miami,
Florida
| – | -$38K | -1,153 | Closed |
|
|
CCM
30
Chilton Capital Management
Houston,
Texas
| – | +$27 | +1 | New |
|
|
LC
31
Lindbrook Capital
Calabasas,
California
| – | +$135 | +5 | New |
|
32
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$162 | +6 | New |
|
SER Hedge Fund Activity: Q4 2021 in Review
35 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q4 2021, worth a combined $5.28M — up 18% from $4.46M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SER positions and 3 closed out — a net gain of 4 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $25.6K. The largest seller was Citadel Advisors, exiting entirely with an estimated $38K sold.
- 35 institutional investors held Serina Therapeutics (SER) as of Q4 2021, up from 31 in Q3 2021.
- Funds reported $5.28M of Serina Therapeutics stock for Q4 2021, up 18% quarter-over-quarter.
- 7 funds opened new Serina Therapeutics positions in Q4 2021 and 3 closed out, a net change of +4 holders.
- The largest Serina Therapeutics buyer in Q4 2021 was Virtu Financial, an estimated $25.6K added.
- The largest Serina Therapeutics seller in Q4 2021 was Citadel Advisors, an estimated $38K sold.
Based on aggregated 13F filings for Q4 2021.